[
  {
    "ts": "2025-12-18T22:12:56+00:00",
    "headline": "Incyte (INCY): Revisiting Valuation After a Strong Year-to-Date Share Price Rally",
    "summary": "Incyte (INCY) has been quietly outperforming the broader biotech space this year, with the stock up about 46% over the past year and more than 40% year to date, drawing fresh attention. See our latest analysis for Incyte. That move has been driven largely by renewed confidence in Incyte’s pipeline and steady revenue growth, with a robust year to date share price return helping to lift its one year total shareholder return and signal building momentum rather than a one off spike. If this kind...",
    "url": "https://finance.yahoo.com/news/incyte-incy-revisiting-valuation-strong-221256547.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4d343548-cfdc-3fa2-9958-1d7a5ea222b2",
      "content": {
        "id": "4d343548-cfdc-3fa2-9958-1d7a5ea222b2",
        "contentType": "STORY",
        "title": "Incyte (INCY): Revisiting Valuation After a Strong Year-to-Date Share Price Rally",
        "description": "",
        "summary": "Incyte (INCY) has been quietly outperforming the broader biotech space this year, with the stock up about 46% over the past year and more than 40% year to date, drawing fresh attention. See our latest analysis for Incyte. That move has been driven largely by renewed confidence in Incyte’s pipeline and steady revenue growth, with a robust year to date share price return helping to lift its one year total shareholder return and signal building momentum rather than a one off spike. If this kind...",
        "pubDate": "2025-12-18T22:12:56Z",
        "displayTime": "2025-12-18T22:12:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FqD7IP1YjoMtOLiC1foWBQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DnvRJ7zmyZqa8oFdfcLgCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-revisiting-valuation-strong-221256547.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-revisiting-valuation-strong-221256547.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T14:30:00+00:00",
    "headline": "EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi",
    "summary": "INCY wins EC approval expanding Minjuvi's label, adding a new indication for relapsed or refractory follicular lymphoma after prior therapy.",
    "url": "https://finance.yahoo.com/news/ec-approves-label-expansion-incys-143000515.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8eef2724-41ed-3a59-bf59-17f50ae0db0a",
      "content": {
        "id": "8eef2724-41ed-3a59-bf59-17f50ae0db0a",
        "contentType": "STORY",
        "title": "EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi",
        "description": "",
        "summary": "INCY wins EC approval expanding Minjuvi's label, adding a new indication for relapsed or refractory follicular lymphoma after prior therapy.",
        "pubDate": "2025-12-18T14:30:00Z",
        "displayTime": "2025-12-18T14:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d7sHwZPFV1U3B4BGoNlXfg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k5CBlnqEqKxZI1S0BuG_ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ec-approves-label-expansion-incys-143000515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ec-approves-label-expansion-incys-143000515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            },
            {
              "symbol": "QGEN"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T13:00:00+00:00",
    "headline": "Incyte to Present at Upcoming Investor Conference",
    "summary": "WILMINGTON, Del., December 18, 2025--Incyte (Nasdaq:INCY) announced today that it will present at the 44th Annual J. P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 am (PST).",
    "url": "https://finance.yahoo.com/news/incyte-present-upcoming-investor-conference-130000853.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "5f5e28ac-234b-3cdc-be89-f75dab1f6e6e",
      "content": {
        "id": "5f5e28ac-234b-3cdc-be89-f75dab1f6e6e",
        "contentType": "STORY",
        "title": "Incyte to Present at Upcoming Investor Conference",
        "description": "",
        "summary": "WILMINGTON, Del., December 18, 2025--Incyte (Nasdaq:INCY) announced today that it will present at the 44th Annual J. P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 am (PST).",
        "pubDate": "2025-12-18T13:00:00Z",
        "displayTime": "2025-12-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/726b801f8aeec41a9022fb0645ca6cf1",
          "originalWidth": 480,
          "originalHeight": 349,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p1BrOc.TFaoiEHBDVi2XbA--~B/aD0zNDk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/726b801f8aeec41a9022fb0645ca6cf1.cf.webp",
              "width": 480,
              "height": 349,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AuEq9E.KbbCF8u.wd3AqNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/726b801f8aeec41a9022fb0645ca6cf1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-present-upcoming-investor-conference-130000853.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-present-upcoming-investor-conference-130000853.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]